insulin glargine (Q21545): Difference between revisions

From Azupedia
Jump to navigation Jump to search
Added link to [en]: Insulin glargine
 
(5 intermediate revisions by the same user not shown)
Property / medical condition treated
 
Property / medical condition treated: hyperglycemia / rank
 
Normal rank
Property / medical condition treated
 
Property / medical condition treated: type-1 diabetes / rank
 
Normal rank
Property / medical condition treated: type-1 diabetes / qualifier
 
start time: 19 April 2000
Timestamp+2000-04-19T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / medical condition treated: type-1 diabetes / qualifier
 
Property / subject has role
 
Property / subject has role: anti-diabetic medication / rank
 
Normal rank
Property / related image
 
Property / related image: Toujeo 300 IU-ml inj.jpg / rank
 
Normal rank
links / en / namelinks / en / name
 

Latest revision as of 09:33, 20 March 2024

pharmaceutical drug
  • HOE-901
  • HOE-71GT
  • Insulin Glargine (rDNA origin)
  • Abasria
Language Label Description Also known as
English
insulin glargine
pharmaceutical drug
  • HOE-901
  • HOE-71GT
  • Insulin Glargine (rDNA origin)
  • Abasria

Statements

0 references
0 references
0 references
C₂₆₇H₄₀₄N₇₂O₇₈S₆
0 references
Toujeo 300 IU-ml inj.jpg
1,400 × 1,050; 894 KB
0 references